The current issue of Feminism & Psychology is an open source special issue focusing on the long-promised, upcoming revision to the Diagnostic and Statistical Manual of Mental Disorders. Entitled “DSM-5 and Beyond: A Critical Feminist Engagement with Psychodiagnosis,” the issue is guest edited by Jeanne Marecek and Nicola Gavey. As they write in their introduction:
The
…
San Francisco October 2012
You may have followed the debates and controversies surrounding the upcoming release of the DSM-V and in particular the proposal to include “attenuated psychosis syndrome” as a diagnostic category. The DSM-V committee originally proposed including attenuated psychosis syndrome as a full diagnosis, but recently backed off in response to pressure from clinicians, researchers and members of …
In recent years, a growing (and pleasingly interdisciplinary) literature has developed around the intersecting themes of neurogenetic ‘explanatory’ narratives, largely pharmaceutically-driven processes of medicalization, stigma and socioclinical identity in the context of psychiatric disorder. In this post I aim to briefly review two of the most immediate and provocative of these publications, and then launch a more free-ranging reflection on …
Cross-posted from The FPR Blog.
John Gever of MedPage Today, has done a terrific summary of the proposed changes to the DSM (“DSM-5: What’s In, What’s Out“).
The umpteenth person just described the DSM-5 process to me as a major rehaul. Is it? Aside from the changes in how we want to sort the world of persons …
Jonathan Metzl’s The Protest Psychosis: How schizophrenia became a black disease (Beacon Press, 2010) is an ideal introductory text for introducing students to ethical issues surrounding politics, prejudice, and psychiatric diagnosis. The reader will experience the indignity and paranoia that African American men being treated for schizophrenia in the 1960s and 1970s had to face. They will come to …
I came across this ad in a 1966 issue of JAMA. This isn’t at all my area of research, but I thought the ad was quite evocative of the changes that have occurred in psychiatry and mental health care over the past thirty years.
Because we now think of Ritalin as a drug used to curb hyperactivity or to focus …